Marinus Pharmaceuticals (NASDAQ:MRNS) Upgraded to Outperform by Oppenheimer
Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) was upgraded by research analysts at Oppenheimer from a “market perform” rating to an “outperform” rating in a note issued to investors on Monday, MarketBeat.com reports. The firm currently has a $6.00 price objective on the biopharmaceutical company’s stock. Oppenheimer’s price objective would suggest a potential upside of […]
More Stories
Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Up 1% – Should You Buy?
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) shares shot up 1% during trading on Tuesday . The company traded...
Lockheed Martin (NYSE:LMT) Trading 0.2% Higher – What’s Next?
Shares of Lockheed Martin Co. (NYSE:LMT – Get Free Report) rose 0.2% during mid-day trading on Tuesday . The company...
Equities Research Analysts’ Upgrades for December 24th (AME, AOSL, BHE, CL, CLNE, DD, DENN, DESP, EAT, ESE)
Equities Research Analysts’ upgrades for Tuesday, December 24th: AMETEK (NYSE:AME) was upgraded by analysts at StockNews.com from a hold rating...
Harmony Price Hits $0.0325 on Top Exchanges (ONE)
Harmony (ONE) traded up 15.3% against the US dollar during the 24 hour period ending at 13:00 PM Eastern on...
MXC Price Tops $0.0057 on Exchanges (MXC)
MXC (MXC) traded 3.3% lower against the dollar during the 24 hour period ending at 13:00 PM Eastern on December...
OPG Power Ventures (LON:OPG) Trading Down 7.7% – Here’s What Happened
OPG Power Ventures Plc (LON:OPG – Get Free Report)’s stock price fell 7.7% on Tuesday . The stock traded as...